Woman and Man
- | Country :
- Ukraine
- United States
- | organs : -
- | Specialty : -
Extract
The study will be conducted at up to 80 centers worldwide and will be a double-blind randomized parallel group placebo controlled study among subjects with stable coronary artery disease (CAD). Subjects will be randomized to receive either placebo tablets or one of 4 orally active doses of A-002. The duration of study drug therapy will be 8 weeks.
Inclusion criteria
- coronary artery disease (CAD)